Diagnostic challenge: Is this really a stroke?

Australian Family Physician

Volumn 35, Issue 10, 2006, Pages 805-808

  Ng, Ching Lue ^a  

^a Hospital Authority   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; ADULT; AGED; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; EPILEPSY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MENINGITIS; MIGRAINE WITH AURA; MULTIPLE SCLEROSIS; TIME;

ABSCESS; ADULT; AGED; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; EPILEPSY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MENINGITIS; MIGRAINE WITH AURA; MULTIPLE SCLEROSIS; TIME FACTORS;

EID: 36048975092     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stroke Australia Task Force. National Stroke Strategy. Melbourne: National Stroke Foundation, 1997.
2. Anderson CS, Jamrozik KD, Broadhurst RJ, et al. Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study. Stroke 1994;25:1935-44.
3. Thrift AG, Dewey HM, Macdonell RA, et al. Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2000;31:2087-92.
4. Wilkinson PR, Wolfe CD, Warburton FB, et al. A long term follow up of stroke patients. Stroke 1997;28:507-12.
5. Saver JL. Time is brain-quantified. Stroke 2006;37:263-6.
6. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999;340:1781-7.
7. Ingall TJ, O'Fallon WM, Asplund K, et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004;35:2418-24.
8. Kwiatkowski T, Libman R, Tilley BC, et al. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med 2005;45:377-84.
9. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDs rt-PA stroke trials. Lancet 2004;363:768-74.
10. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:3(Suppl):483S-512S.
11. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 9: adult stroke. Circulation 2005;112(Suppl):111-20.
12. Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update: a scientific statement from the Stroke Council of the American Heart Association/ American Stroke Association. Stroke 2005;36:916-23.
13. Huff JS. Stroke differential diagnosis: mimics and chameleons. March 2002 Courses at American Academy of Emergency Medicine. Foundation for Education and Research in Neurological Emergencies (FERNE), 2002.
14. Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians: accuracy in diagnosis of stroke. Stroke 1995;26:2238-41.
15. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet 1982;1:328-31.
16. Ferro JM, Pinto AN, Falcao I, et al. Diagnosis of stroke by the nonneurologist: a validation study. Stroke 1998;29:1106-9.
17. American Heart Association. ACLS Provider Manual 2002;197.
18. Gale EAM, Anderson JV. Diabetes mellitus and other disorders of metabolism. In: Kumar P, Clark M, editors. Clinical medicine. Edinburgh: WB Saunders 1998; Ch. 17.
19. Montgomery BM, Pinner CA, Newberrry SC. Transient hypoglycaemic hemiplegia. Arch Int Med 1964;114: 680-4.
20. Malouf R, Brust JC. Hypoglycaemia: causes, neurological manifestations, and outcome. Ann Neurol 1985;17: 421-30.
21. Smith WS, Hauser SL, Easton JD. Cerebrovascular diseases. In: Braunwald, Fauci, Kasper, Hauser, Longo, Jameson, editors. Harrison's principles of internal medicine. New York: McGraw-Hill 2001; Ch. 361.
22. Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr. Will primary central nervous system lymphoma be the most frequent brain tumour diagnosed in the year 2000? Cancer 1997;79:2409-13.
23. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999;43:199-201.
24. Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol 1999;43:219-26.
25. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261-6.
26. DeAngelis LM. Medical Progress: Brain tumours. N Engl J Med 2001;344:114-23.
27. Raskin NH, Peroutka SJ. Headache, including migraine and cluster headache. In: Braunwald, Fauci, Kasper, Hauser, Longo, Jameson, editors. Harrison's principles of internal medicine. New York: McGraw-Hill 2001; Ch. 15.
28. Davidoff RA. Migraine: Manifestations, pathogenesis, and management. Oxford: Oxford University Press, 2002.
29. Jensen K, Tfelt-Hansen P, Lauritzen M, Olesen J. Classic migraine: a prospective recording of symptoms. Acta Neurol Scand 1986;73:359-62.
30. Peatfield RC, Gawel MJ, Clifford RF. Asymmetry of the aura and pain in migraine. J Neurol Neurosurg Psychiatry 1981;44:846-8.
31. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Medical progress: multiple sclerosis. N Engl J Med 2000;343:938-52.
32. Frohman EM, Zimmerman CF, Frohman TC. Neuro-ophthalmic signs and symptoms. In: Burks JS, Johnson KP, editors. Multiple sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos 2000; Ch. 19.
33. Van Den Noort S. Signs and symptoms of multiple sclerosis. In: Olek MJ, editor. Multiple sclerosis: etiology, diagnosis and new treatment strategies. Totowa, New Jersey: Humana Press 2005; Ch. 1.
34. Campbell WW, Pridgeon RM. Practical primer of clinical neurology. Philadelphia: Lippincott Williams & Wilkins, 2002.
35. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective Validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000;31:71-6.